Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Letrozole in combination with Bevacizumab
Sponsor: University of Alabama at Birmingham
Collaborators: Genentech, Inc.